SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-045332
Filing Date
2010-09-07
Accepted
2010-09-07 19:30:21
Documents
1
Period of Report
2010-08-29

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c05725_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c05725_3x0.xml 3 1619
  Complete submission text file 0001209191-10-045332.txt   3645
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 SNUNIT STREET SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address
Palash Tzvi (Reporting) CIK: 0001500830 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 101060926